China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise

Symbols: CSKI
Posted in: News, FDA
Share

China Sky One Medical (NASDAQ: CSKI) today announced that its wholly-owned subsidiary, Harbin Tian Di Ren Medical Science and Technology Company, signed an agreement to jointly set up a new company, Harbin Tian Xin Biological Engineering Ltd.

Harbin Tian Xin Biological Engineering Ltd. is being organized to perform the storage of umbilical cord stem cells. It is also to perform the clinical applications of bone marrow stem cells, intercord mesenchymal stem cells and other human stem cells.


 
 
< Previous
Molycorp Secures Government Approval To Conduct Heavy Rare Earth Exploratory Drilling
Next >
Hollysys Automation Technologies Signed a High-Speed Rail ATP Contract Valued at $4.2M
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust